Many anticancer drugs exert their cytotoxicity through DNA damage and induction of apoptosis. Small cell lung carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC) have dierent sensitivity to treatment with radiation and chemotherapeutic agents with SCLC being more sensitive than NSCLC both in vitro and in vivo. This dierence might be related to the dierent susceptibility of small and non-small cell lung carcinoma to undergo apoptosis. The aim of this study was to investigate if de®ciencies in the apoptotic pathways can explain the intrinsic resistance of NSCLC to anti-cancer treatment. Three dierent triggers were used to induce apoptosis. Etoposide and g-radiation, which are important parts of clinical lung cancer treatment, induce DNA-damage, whereas Fas ligation induces receptormediated apoptotic pathways. NSCLC cells were crossresistant to all treatments, whereas SCLC cells, which do not express pro-caspase-8, were resistant to aFas-, but not to DNA-damage-induced apoptosis. Cytochrome c release, activation of caspase-9 and the executioner caspase-3 were observed in both types of lung cancer cells. However, cleavage of known nuclear substrates for caspase-3, such as PARP and DFF45/ICAD, was documented only in the sensitive SCLC cells but not in the resistant NSCLC cells. Moreover, relocalization of active caspase-3 from the cytosol into the nucleus upon treatment was observed only in the SCLC cell line. These results indicate that the inhibition of apoptosis in NSCLC occurs downstream of mitochondrial changes and caspase activation, and upstream of nuclear events.
Introduction
Lung cancer is the major cause of cancer deaths in the western world and the incidence continues to rise. Based on histopathological features lung cancers are divided into small cell lung carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC) (Sekido et al., 1998) . SCLC and NSCLC are characterized by dierent sensitivity to radio-and chemotherapy. The initial responsiveness of SCLC to anti-cancer drugand radiation treatment is in contrast to the intrinsic resistance observed in NSCLC (Owens and Abelo, 1985) . The reason for this dierence is not fully understood. A common mechanism of various anti cancer therapies, including radiation, is induction of cell death via apoptosis (for review see Zhivotovsky et al., 1999 and references therein) . Thus, dierence in sensitivity to treatment might be dependent on the susceptibility of SCLC and NSCLC to undergo apoptosis. In our previous study a higher level of spontaneous apoptosis was detected in SCLC compared with NSCLC lines (SirzeÂ n et al., 1998) . However, the molecular mechanisms, which can explain this dierence remain elusive.
Apoptosis is a multistage process. The various biochemical events during the initiation phase, when the cells receive the apoptotic stimulus, constitute some speci®c pathways, which closely depend on the nature of each stimulus. The type of apoptotic trigger can determine the time frame within which apoptosis occurs. At the beginning of the execution phase, the trigger-speci®c pathways converge at two points: the mitochondria and the caspases (Rich et al., 1999; Green, 2000) . At these points the cells are thought to be irreversibly committed to apoptosis. During receptor-mediated apoptosis the activation of pro-caspase-8 plays a key role. In non-receptor-mediated apoptosis, including radiation-induced killing, the release of mitochondrial proteins like cytochrome c and the activation of pro-caspase-9 within the apoptosome complex seem to commit the cell to the pathway leading to cell death (Green, 2000; Budihardo et al., 1999) . In both cases, the activation of enzymes such as caspases and nucleases leads to the appearance of the morphological and biochemical hallmarks of apoptosis (Budihardo et al., 1999) .
Molecular participants in the apoptotic program are located in dierent subcellular compartments, such as the plasma membrane, cytosol, mitochondria, endoplasmic reticulum and nucleus. The interplay among these compartments and the exchange of speci®c signaling molecules are critical for the systematic progression of apoptosis. As was mentioned above, recent studies demonstrate the ability of the two main initiator caspases (8 and 9) to signal via distinct pathways and activate the eector pro-caspase-3 within the cytosol. Caspase-3 is responsible for cleaving various death substrates, many of which are involved in regulating nuclear changes in apoptosis. Thus, cleavage of dierent target proteins is followed by condensation of chromatin, endonuclease activation is followed by cleavage of DNA, and nuclear fragmentation is followed by formation of apoptotic bodies, all which are phenomena that are characteristic of nuclear apoptosis (Robertson et al., 2000) . Although signi®cant progress has been made to speci®cally de®ne and characterize the participation of nuclear changes in apoptotic cell death, this area still requires further investigation.
In a previous study we investigated the expression of several pro-caspases in a panel of 16 SCLC and NSCLC cell lines. While pro-caspases-2, -3, -6, -7, and -9 were found in both SCLC and NSCLC cells, procaspases -1, -4, and -10 were only expressed in NSCLC cell lines. The presence of pro-caspase-8 were also limited to the NSCLC type, with the exception of one SCLC cell line, U1285. Thus there seems to exist a de®ciency of several pro-caspases in SCLC .
The aim of this study was to investigate the activation of the apoptotic signaling pathways in the SCLC and NSCLC cell lines after treatment with a broad spectrum of stimuli including receptor stimulation (aFas), treatment with a cytotoxic drug (etoposide) and g-radiation. From the panel of cells previously tested , we selected the three following lung cancer cell lines: H82, a SCLC cell line which is pro-caspase-8 negative, U1285 (a SCLC cell line) and U1810 (a NSCLC cell line), both expressing pro-caspase-8. The SCLC cell lines were sensitive to ionizing radiation, VP16, and, depending on their pro-caspase-8 status, also to agonistic aFas treatment. U1810 cells were crossresistant to all apoptotic stimuli used. Investigation of the components of the apoptotic machinery revealed no signi®cant dierences between cells concerning the activation of apical caspases-8 and -9, the subsequent activation of executioner caspases, such as caspase-3, or the release of cytochrome c into the cytosol. The cleavage of the nuclear proteins poly(ADP-ribose)polymerase (PARP) and DNA fragmentation factor-45 (DFF45)/inhibitor of caspase-activated DNase (ICAD) has been described as dependent on caspase activity (Tewari et al., 1995; Sakahira et al., 1998) . Investigation of dierent biochemical hallmarks of nuclear apoptosis, revealed that the nuclear events (cleavage of PARP and DFF45/ICAD as well as DNA fragmentation) do not occur in the NSCLC cell line even though caspase-3 was activated in these cells. In addition, the relocalization of active caspase-3 from cytosol into the nucleus was observed in the U1285 SCLC cell line, but did not occur in all NSCLC cell lines tested (U1810, H157 and H23). These results clearly indicate that the inhibition of apoptosis in NSCLC cell lines occurs downstream of cytochrome c release and caspase activation but upstream of nuclear apoptotic event(s).
Results
Nuclear morphological changes are observed in SCLC but not in NSCLC after aFas, VP16 and g-irradiation Morphological features of apoptosis were identi®ed after co-staining of cells with Hoechst 33342 and PI. In situ nuclear DNA fragmentation was measured by using the TUNEL technique (Figure 1) . A TUNELpositive fraction was detected in untreated U1285 and H82 cells (Figure 1b,c, lane 1) , which re¯ects the amount of cells that spontaneously undergo apoptosis in these cell lines. This is in accordance with our earlier published ®nding (SirzeÂ n et al., 1998) . Jurkat cells were used as a positive control in all experiments ( Figure  1a ). Morphological changes induced by aFas were detected earlier than those induced by VP16 treatment or g-radiation (3 h vs 48 h) ( Figure 1a , lanes 2 ± 4). The two SCLC cell lines, U1285 and H82, revealed an increase in the TUNEL-positive fraction after VP16 and g-radiation treatments (Figure 1b ,c, lanes 3 and 4 and Table 1 ). aFas treatment induced an early increase of the TUNEL-positive fraction in U1285 cells ( Figure  1b , lane 2, 12 h) while it failed to do so in H82 cells ( Figure 1c , lane 2, 48 h). The resistance to receptormediated killing in H82 is in agreement with the lack of pro-caspase-8 expression in this cell line. No TUNEL-positive fraction or morphological features of apoptosis were detected in U1810 cells, before or after any treatment. No signs of nuclear apoptosis in response to any of these stimuli were detected in U1810 cells up to 48 h post-treatment ( Figure 1d and Table  1 ). Similar results were obtained after co-staining of cells with Hoechst and PI (data not shown).
It is known that DNA-damaging agents might induce apoptosis and/or cell cycle arrest. Therefore it was of interest to understand if apoptosis induced by these agents is a pre-or post-mitotic event. Since U1810 cells showed no signs of nuclear apoptosis after treatment with DNA-damaging agents, such as g-radiation or VP16, we performed a time course analysis of several parameters (cell survival, cell cycle distribution, appearance of a sub-G 1 cell population, release of cytochrome c, activation of dierent caspases and cleavage of speci®c proteins) in these and other cells before and after treatment (Table 1 and data not shown). The detail analysis of cell cycle distribution revealed that 24 h posttreatment with VP16 and g-radiation both U1810 and U1285 cells sense DNA damage and arrest in G2/M (data not shown). In these cell lines the proportion of cells in G2/M was increased three and ®ve times after VP16 and seven and eight times after g-radiation treatment as compared to the control (values for U1285 cells and U1810 cells, respectively). The G2 arrest in U1285 cells was indeed followed by the appearance of a sub-G1 cell population (Table 1 and data not shown), the appearance of nuclear apoptotic morphology as well Figure 1 DNA fragmentation and nuclear apoptotic morphology after treatment with aFas, VP16 or g-irradiation in SCLC and NSCLC cell lines. Untreated (1) and treated either with 250 ng/ml aFas (2), or 1.5 mg/ml VP16 (3) or 8 Gy g-irradiation (4) Jurkat (T cells) (a), U1285 (b), H82 (c), and U1810 (d) cells were analysed at the indicated times using the TUNEL assay as described in Materials and methods. Hoechst 33342 and PI co-staining were used to observe nuclear morphological changes and to discriminate apoptotic cells from the necrotic cells, respectively. Representative data from one out of three independent experiments are included (Figure 1c ), whereas this did not occur in U1810 cells ( Figure 1d and Table 1 ). The cell cycle distribution 24 h after aFas treatment did not reveal signi®cant changes in both cell lines tested (data not shown).
Pro-caspase-8 processing in U1285 and U1810 cells after treatment with aFas, VP16 or g-radiation
The dierent sensitivity of SCLC and NSCLC cells to treatment could depend on the eectiveness of the apoptotic machinery. Therefore, we focused our investigation on several important steps in the propagation of the apoptotic process. During receptor-mediated killing the activation of pro-caspase-8 plays a key role. SCLC and NSCLC cell lines dier in the expression of pro-caspase-8. In all SCLC cell lines tested, except U1285, no expression of this pro-enzyme was observed Figure 2 ; U1285 vs H82). In untreated cells pro-caspase-8 is present in two isoforms with molecular weights of 55 and 53 kDa, respectively (Scadi et al., 1997) . Processing of the pro-form was observed in all cell lines expressing pro-caspase-8 (U1285, U1810, and Jurkat) after all three types of treatments used ( Figure 2 ). After stimulation of cells with agonistic anti-Fas antibodies conversion of pro-caspase-8 to active caspase-8 was observed at an earlier time point compared with treatment with VP16 or g-radiation ( Figure 2 ). To con®rm the activation of pro-caspase-8, the cleavage of uorogenic substrate IETD-AMC was measured in untreated and g-irradiated U1285 and U1810 cells and results are present in Table 1 . It is noteworthy that even though no pro-caspase-8 expression was detected in H82 cells, they still underwent apoptosis upon VP16 and g-radiation treatments (Figures 1 and 2 ). In U1810 cells pro-caspase-8 is present and functional, since a proteolytic activation and cleavage of¯uorogenic substrate by this protease upon various treatments was observed ( Figure 2 and Table 1 ). However, the presence/activation of this enzyme was not sucient to drive these cells to undergo apoptosis.
Cytochrome c release into cytosol is detected upon apoptotic induction in both SCLC and NSCLC cell lines Pro-caspase-8 was cleaved and activated in U1810 cells exposed to apoptotic stimuli, hence the block in the apoptotic pathway must be further downstream, either on the stage of activation of executional caspase, such as caspase-3, or at the level of mitochondria. Mitochondria play an important role in the regulation of apoptosis by the release of cytochrome c, which activates cytosolic caspases and thereby triggers the execution phase of apoptosis. The regulation of cytochrome c release from mitochondria into the cytosol might explain the dierent propensities of SCLC and NSCLC cells to undergo apoptosis. Consequently, the appearance of cytochrome c in cytosol on these cells upon treatment was analysed using an antibody against cytochrome c.
A 12-kDa polypeptide in cytosolic extracts was detected by Western blot technique after aFas, VP16 or g-radiation treatment in Jurkat and U1285 ( Figure  3a and Table 1 ). In H82 and U1810 cells, release of cytochrome c was detected only after g-radiation and VP16 treatment. However, no band at 12 kDa was observed after aFas treatment in these two cell lines ( Figure 3a ). The release of cytochrome c was con®rmed using an immunohistochemical approach. Immunouorescent detection of cytochrome c normally yields a pattern of punctate cytoplasmic staining with some preference for the perinuclear area ( Figure 3b , left panel). This pro®le of staining is typical for proteins with mitochondria localization. As shown in Figure 3b , release of cytochrome c into the cytosol was observed in both U1810 and U1285 cells 24 h after irradiation (untreated cells panels B1 and B3, treated cells panels B2 and B4). Upon radiation treatment, cytochrome c staining lost its punctate pattern and became considerably more diuse. These results correlate with data obtained by immunoblotting and show that in both U1285 and U1810 cells release of cytochrome c is time dependent, although much more cytochrome c is released from mitochondria of U1285 cells as compared to U1810 cells (Table 1 and data not shown for other types of treatment).
Caspase-9 activity is detected upon treatment with aFas, VP16 or g-radiation in both SCLC and NSCLC cell lines
In non-receptor-mediated apoptosis, including radiation-induced killing, the release of mitochondrial proteins and the following activation of pro-caspase-9 in the apoptosome complex seems to be the committing event in the pathway leading to cell death (Green, 2000; Budihardo et al., 1999) . The processing of procaspase-9 and activity of caspase-9 were investigated by Western blot technique and by measuring the cleavage of the¯uorogenic substrate LEHD-AMC, that corresponds to a preferred cleavage site for this protease, respectively (Figure 4a ,c, Table 1 ). A basal caspase-9 activity was observed in all lung cancer cell lines tested. Activation of pro-caspase-8 upon induction of apoptosis. U1285, H82, U1810 and Jurkat cells treated with 250 ng/ml aFas, 1.5 mg/ml VP16 or 8 Gy g-irradiation were harvested and lysed at the indicated times after treatment. Protein extracts were analysed by Western blot for the presence of the pro-caspase-8 (55 ± 53 kDa) and the active form (43 ± 41 kDa). G3PDH was used as a standard for the equal loading of protein in the lanes (data not shown)
No basal activity was detected in untreated Jurkat T cells, but was induced in these cells 6 h after aFas and 24 h after VP16 or g-radiation treatment. An increase in caspase-9 activity was found in U1258 and H82 SCLC cell lines 24 h after VP16 treatment (*3.5 times) and 8 Gy g-irradiation (*11 times). Furthermore, aFas treatment induced a twofold increase (24 h) in the caspase-9 activity in U1285 cells, whereas this did not Figure 3 Release of mitochondrial cytochrome c upon apoptotic stimuli in SCLC and NSCLC cells. (a) Cells treated with 250 ng/ ml aFas, 1.5 mg/ml VP16 or 8 Gy g-irradiation were harvested after 8 h, except for aFas treated Jurkat cells which were harvested at 3 h. Cytosol extracts were analysed by Western blot for the presence of cytochrome c using the anti-cytochrome c antibody (clone 7H8.2C12) as described in Materials and methods. Actin was used as a standard for equal loading of protein. (b) Indirect immuno¯uorescence of cytochrome c using the anti-cytochrome c antibody (clone 6H2-B4) was investigated in U1285 (1, 2) and U1810 cells (3, 4). Untreated (1, 3) and g-irradiated (2, 4) cells were analysed 24 h post-treatment Figure 4 Caspase-9 and caspase-3-like activities in SCLC and NSCLC cells. Cells were incubated with 250 ng/ml aFas, 1.5 mg/ml VP16 or 8 Gy g-irradiation for 24 h, except for aFas treated Jurkat cells, which were incubated for 6 h. Caspase-9 activity (a) and caspase-3-like activity (b) were determined by the cleavage of the speci®c peptide substrates LEHD-AMC (50 mM) and DEVD-AMC (50 mM), respectively. The maximum linear rate of AMC release (pmol/min) was estimated by linear regression (r 2 40.99). Data shown are the average of three independent experiments performed in duplicate. (c) Western blot analysis of activation of procaspases-3, and -9 in g-irradiated U1285 and U1810 cells. G3PDH was used as a standard for the equal loading of protein in the lanes. This is a representative blot from three independent experiments occur in H82 cells. Caspase-9 activity in U1810 NSCLC cells increased 2.5, 1.5 and 5.2 times at 24 h upon aFas, VP16, and 8 Gy g-irradiation, respectively ( Figure 4a and Table 1 ). Even though LEHD-AMC is the best known substrate for active caspase-9, other caspases are also able to cleave this substrate, albeit with lesser eciency (Garcia-Calvo et al., 1999) . Therefore the activation of pro-caspase-9 was con®rmed by Western blot analysis of protein extracts isolated from treated U1285 and U1810 cells. As shown in Figure 4c disappearance of the 45 kDa band of native pro-caspase-9 started at 6 h and became evident at 24 h after g-irradiation in U1285 cells. Decrease of the same band in U1810 cells started at 24 h upon radiation treatment (Figure 4c) . A similar tendency was observed in cells treated with VP16 (data not shown).
Caspase-3-like activity is observed in both SCLC and NSCLC cells upon treatment with aFas, VP16 or g-radiation Receptor-and non-receptor-mediated apoptosis converge at a common pathway where activation of the executioner caspases (caspases-3, -6, and -7) takes place. To investigate if the resistance of U1810 to undergo apoptosis could be caused by a defect at the execution phase, the caspase-3-like activity was analysed in SCLC and NSCLC cells after dierent types of treatments (Figure 4b ). DEVD-AMC is ā uorogenic substrate cleaved by both caspases-3 and -7. Increased release of AMC was detected at 6 h after aFas treatment of Jurkat cells and 24 h upon all types of treatment in all cell lines (Jurkat, U1285, H82, and U1810). However, in aFas stimulated H82 cells, the level of caspase-3-like activity was much lower as compared to the activity induced by g-radiation or VP16 in the same cells or that induced by aFas in U1285 and U1810 cells. The activation of pro-caspase-3 in both types of cells was time-dependent (Table 1 and data not shown). These results were con®rmed by cleavage of the native 32 kDa protein with formation of the 17 kDa subunit of the active enzyme in Western blot experiments (Figure 4c and data not shown for other types of treatment).
PARP and DFF45/ICAD cleavage occurs in SCLC but not in NSCLC cell lines PARP is a well-known substrate for caspases-3 and -7 (Tewari et al., 1995; Germain et al., 1999) and cleavage of this nuclear protein is one of the biochemical hallmarks of apoptosis. We investigated whether cleavage of PARP also takes place in lung cancer cells undergoing apoptosis. In untreated U1285 and H82 cells the native 116 kDa polypeptide along with an additional band corresponding to the 89 kDa cleavage product was detected by immunoblotting (Figure 5a ). This spontaneous cleavage has been described previously and correlates with the level of spontaneous apoptosis in SCLC cells . In untreated U1810 and Jurkat cells only the 116 kDa PARP was present (Figure 5a) . Activation of the receptor-(aFas) and of the non-receptor-(VP16 or gradiation) mediated apoptotic pathways in Jurkat T cells led to the appearance of the 89 kDa band. No change in native PARP was detected in U1810 up to 48 h post-treatment (Figure 5a ). The speci®city of caspase dependent cleavage of PARP in SCLC cells was con®rmed using the broad range caspase inhibitor, zVAD-fmk. As shown in Figure 5b , 1 h pre-incubation of cells with zVAD-fmk resulted in a marked inhibition of the processing of PARP in untreated U1285 as well as in aFas-treated U1285 and Jurkat cells. Caspase-3 initiates apoptotic DNA fragmentation by inactivation of DFF45/ICAD and release of active DFF40/CAD (caspase-activated DNase) (Sakahira et al., 1998) . Western blot shows the disappearance of the 45 kDa native DDF45/ICAD upon apoptosis induction in U1285 cells (Figure 5c ). The absence of the cleavage products in the blots is due to the speci®city of the antibody, which cannot recognize the cleavage fragment of DFF45. To quantify the decrease in the level of DFF45 in apoptotic cells densitometric analysis of bands corresponding to DFF45 and G3PDH was performed. The ratio between optical density of DFF45 and G3PDH (Figure 5c ) revealed that 18, 23 and 28 per cent of native DFF45 was degraded in U1285 cells treated with aFas, etoposide and radiation, respectively. No signi®cant changes in the presence of the native band of DFF45/ICAD were observed after treatment of U1810 cells (Figure 5c ).
Nuclear relocalization of active caspase-3 after g-radiation is observed in SCLC but not in NSCLC cell lines Western blot analysis of the cleavage of nuclear caspase-3 substrates, PARP and DFF45/ICAD, revealed a dierence in their degradation in the two cell types ( Figure 5 ) and suggested that active caspase-3 might be translocated from the cytoplasm to the nucleus in SCLC cells but not in the NSCLC cells. To con®rm this possibility, co-staining of nuclei with DAPI and antibody against the active form of caspase-3 (biotinylated monoclonal antibodies detected by streptavidin-FITC) was performed. The speci®city of this Ab was tested in several experiments. Thus, apoptotic MCF-7 cells were negatively stained, as they are caspase-3 de®cient. In¯ow cytometry experiments, when the antibody against active caspase-3 was preincubated with recombinant active caspase-3 (which is composed of both the large and small subunits in the form of a heterodimer) the reactivity of the Ab was blocked (data not shown). The speci®city of this Ab was also recently documented by another group (Hartmann et al., 2000) . Results presented in Figure  6 showed a positive staining against active caspase-3 24 h after irradiation in both types of lung cancer cells as compared to the control. However, cytosolic as well as nuclear localization of active caspase-3 was observed only in treated U1285 cells. Nuclear staining of active caspase-3 was stronger in condensed nuclei of U1285 cells. In irradiated U1810 cells the presence of active caspase-3 was restricted to the cytosol. To investigate if failure to relocalize active caspase-3 to the nucleus is restricted to U1810 cells, experiments using two additional NSCLC cell lines (H23 and H157) were performed. These cell lines were previously characterized (SirzeÂ n et al., 1998; Joseph et al., 1999) and similar to U1810 cells did not display radiation-induced DNA fragmentation. No translocation of active caspase-3 into the nucleus of irradiated cells was observed in both H23 and H157 cells (Figure 6 ), suggesting that this is a more general phenomenon occurring in all tested NSCLC cell lines.
Discussion
Many anticancer agents exert their cytotoxicity through DNA damage and induction of apoptosis. Although both types of lung cancer cells, SCLC and NSCLC, sensed DNA damage induced by ionizing radiation or VP16 treatment, as shown by the cell cycle arrest, this failed to induce the killing of NSCLC cells. The SCLC cell line (U1285) was sensitive to apoptotic stimuli, such as agonistic anti-Fas antibodies, VP16 and g-radiation treatment. H82, the other SCLC cell line, which lacks pro-caspase-8 expression, displayed an increase of the TUNEL-positive fraction upon treatment with VP16 and g-radiation but did not respond to aFas-stimulus, as expected in consistency with an essential requirement of pro-caspase-8 for the initiation of the Fas-induced apoptotic cascade (Muzio et al., 1996) . Based on the detection of nuclear DNA fragmentation, U1810 NSCLC cells were found to be cross-resistant to all types of treatment described above. A similar observation has been made recently using the JA1.2 resistant variant of Jurkat cells (Boesen-de-Cock et al., 1999). The multi-resistance of U1810 cells to dierent stimuli suggests that the factor(s) responsible for this resistance are involved in the execution phase of the apoptotic process.
In membrane receptor-mediated apoptosis, the activation of pro-caspase-8 plays a key role (for review see Green, 2000) . Targeted disruption of the mouse caspase-8 gene abolishes cell death induction by the TNF/Fas receptor (Varfolomeev et al., 1998) . The lack of pro-caspase-8 expression in H82 cells correlates with the inability of these cells to undergo apoptosis upon aFas treatment. Nevertheless, the pro-caspase-8 de®cient H82 cell line is prone to undergo apoptosis upon VP16 and g-radiation treatment. It seems that the processing of pro-caspase-8 in U1285 cells is a secondary event that ampli®es the apoptotic signal and this processing is not a crucial event in apoptosis induced by nonreceptor mediated triggers (Boesen-de-Cock et al., 1999; Sun et al., 1999) . Indeed, recent studies have shown that in T lymphocytes, anti-cancer drugs or ionizing radiation do not require CD95 receptor/ligand interaction to induce pro-caspase-8 processing (Wesselborg et al., 1999; Belka et al., 1999) , and also that apoptosis induced by these treatments does not involve signals transduced by Fas and FADD (Newton and Strasser, 2000) . All together these data indicated that Figure 5 Caspase-dependent cleavage of PARP and DFF45/ICAD upon apoptotic stimuli. Cells were incubated with 250 ng/ml aFas, 1.5 mg/ml VP16 or 8 Gy g-irradiation for 24 h (a, c), except for aFas treated Jurkat cells, which were incubated for 6 h (a). In (b) cells were pretreated for 1 h with the caspase inhibitor zVAD-fmk (10 mM). Cells were harvested and lysed as described in Materials and methods, and protein extracts were analysed by Western blot for the presence of 116 kDa intact PARP and its 89 kDa cleavage fragment (a, b) and DFF45 (c). G3PDH was used as protein loading standard. These are representative blots from four independent experiments the presence/activation of pro-caspase-8 does not appear to determine the propensity of lung cancer cell to undergo apoptosis.
In non-receptor-mediated apoptosis, cell death induced by drugs and radiation requires a mitochondrial event culminating in the release of mitochondrial cytochrome c to the cytosol and the following formation and activation of the apoptosome complex. This leads to the processing of pro-caspase-9, which in turn cleaves and activates executioner caspases including pro-caspases-3, -6, and -7. Indiscriminately to their sensitivity to undergo apoptosis-speci®c nuclear changes upon radiation or drug treatment, the SCLC and NSCLC, used in this study, responded to the dierent apoptotic stimuli with release of cytochrome c into the cytoplasm and the subsequent activation of pro-caspase-9. Furthermore, activation of executioner caspases such as pro-caspase-3 was observed in both radiation-sensitive (SCLC) and radiation-resistant (NSCLC) cells. A recent report suggests that at least some cells may survive the release of mitochondrial cytochrome c into the cytoplasm and may maintain clonogenic activity (Chen et al., 1998) . In this case the release of cytochrome c does not inevitably lead to caspase activation and cell death. It has also been shown that overexpression of Bcl-2, in addition to its prevention of the release of cytochrome c, can prevent activation of caspases in cells containing cytosolic cytochrome c (Rosse et al., 1998; Zhivotovsky et al., 1998) . Whether there are only one or several protein factors that are involved in the regulation of caspase activation downstream of the apoptosome complex remains to be elucidated. The release of cytochrome c is an essential but not a sucient factor for cell death. There are now several examples of caspase activation without cell death. Thus, activation of caspase-3 like enzymes was reported in non-apoptotic T lymphocytes (Miossec et al., 1997; Wilhelm et al., 1998) . The authors provided evidence for caspase-mediated cleavage of PARP in the absence of DNA fragmentation and apoptosis. Recent data appear to con®rm that caspases are, indeed, activated in non-apoptotic cells and furthermore, that caspases may be required for T cell proliferation in vitro (Alam et al., 1999; Kennedy et al., 1999) . Moreover, Alam et al. (1999) observed activation of caspase-3, -6, -7 and -8 and cleavage of PARP upon T cell activation, while other substrates such as DFF45 were spared, thus likely avoiding apoptotic' fragmentation of DNA in these cells. Furthermore caspases have been implicated in the negative regulation of erythropoiesis (DeMaria et al., 1999) . Finally, it was found that caspases are involved in the maintenance of cytoskeletal integrity in adherent cells (Watanabe and Akaike, 1999), an observation Figure 6 Relocalization of active caspase-3 from cytosol to the nucleus in irradiated cells. Double¯uorescence staining of the nuclei (DAPI, blue) and for the active form of caspase-3 (FITC, green) was performed as described in Materials and methods. Cells were incubated for 48 h upon 8 Gy g-irradiation. Staining was performed on cytospin preparations for U1285 cells and on cells grown on coverslips for U1810, H157 and H23 cells. White arrows indicate accumulation of active caspase-3 in the nuclei which challenges the current view that caspase activation inevitably leads to disintegration of the cytoskeletal structure. Hence, the functional repertoire of the caspases has been extended to encompass not only apoptosis, but also proliferation, pro-and antidierentiation and cells can survive in the presence of active caspases. It is also possible that an apoptotic process might be inhibited downstream of the caspase activation.
Tumor cells express several proteins, such as antiapoptotic members of the Bcl-2 protein family, members of IAPs family, as well as Hsp's, that render them resistant to apoptosis (JaÈ aÈ ttelaÈ , 1999; Tamm et al., 1998; Gross et al., 1999) . It has been shown that in many cancers the Bcl-2/Bax ratio correlates with sensitivity to apoptosis induced by diverse stimuli. However, the Bcl-2/Bax ratio was higher in SCLC cell lines, which are more prone to undergo spontaneous and induced apoptosis, compared with NSCLC cell lines . Furthermore, no conversion of Bcl-2 to Bax-like death eector by a caspasedependent cleavage (Cheng et al., 1997; Fadeel et al., 1999) was observed in treated SCLC cells (B Joseph, et al., 2001, unpublished observation) . In addition, NSCLC and SCLC cell lines did not show dierences in the expression of the Bcl-x L . These observations suggest that the expression of Bcl-2, Bax and Bcl-x L does not explain the resistance of NSCLC cells to undergo apoptosis.
The strongest evidence for IAP involvement in cancer progression comes from the studies on survivin, which is not expressed in dierentiated tissues but is present in most cancers studied, with the highest levels in breast and lung cancers (Tamm et al., 1998) . SCLC and NSCLC cell lines express a high and rather equal level of survivin protein (B Joseph, et al., 2001, unpublished observation) . Thus, this observation excludes dierences in survivin expression as an explanation for the sensitivity of lung carcinomas to anti-cancer treatments.
Several recent publications revealed an important role of heat-shock proteins in apoptosis. Hsp70 has been proposed to exert a protective eect against apoptosis by targeting one or more steps downstream of caspase-3 (Xanthoudakis and Nicholson, 2000) . JaÈ aÈ ttela et al. (1998) have found recently that elevated levels of Hsp70 prevents the morphological changes that are characteristic of dying cells as well as death of tumor cells despite the presence of cytochrome c and active caspase-3 in the cytosol. The possibility that a high level of HSPs might play a role in resistant tumor cells to maintain this balance remains to be elucidated. In any case it is clear that cells can survive in the presence of active caspases.
The activation of caspases during apoptosis is followed by the proteolysis of numerous proteins located in dierent intracellular compartments. The selective localization of pro-caspases in dierent subcellular compartments may play an important role in their activation. The translocation of active caspases to other subcellular compartments appears to be critical for the propagation of the apoptotic process (Zhivotovsky et al., 1999a) . In apoptotic Jurkat cells, translocation of active caspase-3 into the nuclear fraction has been reported (Zhivotovsky et al., 1999a) . Caspase-3-like activity was observed in both SCLC and NSCLC (Figure 4) . The propensity of these cells to undergo nuclear apoptosis (for explanation see Introduction) does not depend on the expression/ activation of pro-caspase-3 but probably on the eciency of the active enzyme to translocate to the nucleus upon apoptotic stimuli. A de®ciency in the relocalization of active caspases into the nucleus, and consequently the absence of proteolysis of speci®c nuclear substrates may account for the lack of the biochemical and morphological nuclear changes in the resistant cell line U1810. The caspase dependent cleavage of PARP as demonstrated by its inhibition by zVAD-fmk, as well as the disappearance of DFF45/ ICAD in sensitive U1285 cells upon treatment and the absence of cleavage of these nuclear proteins in the resistant U1810 cells argues in favor of this hypothesis. There are contradictory results concerning the intracellular localization of DFF45/ICAD (Liu et al., 1997; Sakahira et al., 1998) . In our previous study DFF45 was detected in both cytoplasm and in the nuclei of untreated cells (Zhivotovsky et al., 1999a) and the absence of DFF45 in the nuclei of apoptotic cells was explained by its cleavage in this intracellular compartment. In addition a decrease in the activity of DNAPKcs upon g-radiation, which re¯ects the proteolytic inactivation of this enzyme by the caspases in the nucleus, was observed in U1285 cells, whereas it did not occur in U1810 cells (R Lewensohn, 2001, unpublished observation) . The strongest evidence for a defective apoptotic signal transduction pathway of pro-caspase-3 in NSCLC is the absence of relocalization of active caspase-3 into the nucleus of the U1810 cells after g-radiation, whereas it occurs in the U1285 SCLC cells. Additional experiments using two more NSCLC cell lines (H23 and H157) were performed and further con®rmed that the absence of translocation of active caspase-3 into the nucleus of irradiated cells is not restricted to U1810 cells but is a more general phenomenon occurring in all tested NSCLC cell lines. A previous study has shown that a high level and nuclear localization of caspase-3 play an important role in regulating the apoptosis process in neuroblastomas with favorable prognosis (Nakagawara et al., 1997) .
It has recently been suggested that some cancer cells might undergo delayed or slow cell death (Blagosklonny, 2000) . In this case oncogenic Ras, Raf and mitogen-activated kinases may arrest growth and cause slow cell death with delayed DNA fragmentation. Is it possible that caspases are activated only in some of NSCLC cells and that these cells undergo apoptosis and the other cells survive? We cannot completely exclude this possibility, however there are some evidences against this point of view. First, delayed or slow cell death perpetuates with DNA fragmentation and we were not able to observe this in treated NSCLC cells. Second, delayed cell death occurs without caspase activation and in our experiment the activity of caspase-3 in treated NSCLC cells was even higher than in SCLC, although one should admit that it is not clear to what level caspases need to be activated to kill cells. Third, there are certain criteria to characterize apoptosis that have been discussed extensively (Vaux, 1999) . Many of these criteria were used in our study and we feel strongly that NSCLC cells, despite caspase activation, do not undergo apoptosis at all. There is no TUNEL-positivity, no DNA fragmentation, no formation of hypoploidy, no cleavage of cytosolic proteins, and no nuclear morphological changes. Fourth, following their arrest in G2/M, NSCLC cells recover and continue to grow exponentially for at least 2 weeks.
This study on small-and non-small cell lung carcinoma with dierent sensitivity to anti-cancer treatments is, to our knowledge, the ®rst report describing resistance of NSCLC cells to undergo nuclear apoptosis based on a de®ciency in the relocalization of active caspase-3 into the nucleus, and consequently the absence of proteolysis of speci®c nuclear proteins. Thus, it appears that in NSCLC the apoptotic process is inhibited downstream of mitochondrial changes and caspase activation and upstream of nuclear events. This may then, at least partially, explain resistance of NSCLC tumors to radio-and chemotherapy. (Osaka, Japan), and the caspase inhibitor zVAD-fmk from Enzyme Systems Products (Dublin, CA, USA).
Materials and methods

Antibodies and reagents
Cell culture and treatments
Two previously characterized SCLC cell lines: U1285 (Bergh et al., 1982) , and NCI-H82 (ATCC HTB-175), one NSCLC cell line U1810 (SirzeÂ n et al., 1998) and Jurkat cell line (human T cell leukemia, ATCC TIB 152) were used in this study. Two additional NSCLC cell lines, H157 and H23 (Bergh et al., 1985) were used for investigation of the localization of active caspase-3. Cells were cultured at 378C, 5% CO 2 in a RPMI medium 1640 supplemented with 10% heat-inactivated fetal calf serum, 2 mM L-glutamine, penicillin (100 U/ml) and streptomycin (100 mg/ml). Twenty-four hours after seeding in culture dishes with fresh medium cells were treated by adding aFas (250 ng/ml) or VP16 (1.5 mg/ml), or by g-radiation (8 Gy, SSD 65 cm, 1.5 Gy/min) at ambient room temperature. Controls were mock irradiated. The cell permeable caspase inhibitor zVAD-fmk (10 mM) was added 1 h before treatment. The cell density was kept at levels allowing exponential growth.
Western blot analysis
Laemmli's loading buer (100 ml/10 6 cells) was added to harvested cells and samples were boiled for 3 min. Thirty ml of protein extracts were resolved on 7.5, 12 or 15% SDS polyacrylamide gel at 130 V and transblotted onto nitrocellulose membranes (0.2 mm) for 2 h at 100 V. Membranes were blocked overnight in a buer (50 mM Tris, pH 7.5, 500 mM NaCl) supplemented by 1% bovine serum albumin and 5% non-fat milk powder and probed with primary antibody for 1 h, except for pro-caspase-8 (overnight), in blocking solution without milk, followed by secondary antibody for 1 h in an identical solution. After repeated washing in PBS bands were visualized by ECL according to the manufacturer's instruction.
Caspase activity assay
Caspase-3-like, caspase-8 and caspase-9 activities were determined¯uorometrically using as substrate DEVD-AMC, IETD-AMC or LEHD-AMC, respectively, in a buer containing 100 mM HEPES, pH 7.0, 10% sucrose, 0.1% 3-[(3-holamidopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS), 5 mM DTT, 10 76 % Nonidet P-40 (for caspases-3 and -8), or 100 mM MES, pH 6.5, 10% sucrose, 0.1% CHAPS, 5 mM DTT, 10 76 % Nonidet P-40 (for caspase-9) (Garcia-Calvo et al., 1999) .
TUNEL assay
At dierent time points post-treatment, 15610 4 cells were harvested and cytospins were prepared. Slides were stored at 7208C. In situ nuclear DNA fragmentation was measured according to a method based on 3'OH end labeling of DNA breaks with deoxyuridine terminal deoxynucleotidyl transferase (TdT), with minor modi®cations (Gavrieli et al., 1992) . Samples were rehydrated with PBS for 5 min, ®xed in 1% paraformaldehyde (pH 7.4) (Merck, Darmstadt, Germany) for 15 min at 48C, and washed twice with PBS. The TUNEL reaction was carried out by incubating cells for 1 h at 378C in a moist chamber with 1 nmol/ml FITC-12-dUTP (Roche, Germany), 25 mM CoCl 2 , 25 U/ml TdT (Roche) and TdT buer (125 mM Tris-HCl, 1 M potassium cacodylate, 1.25 mg/ml BSA, pH 6.6). After washing in ice-cold PBS for 5 min slides were co-stained with Hoechst 33342 (Molecular Probes, Oregon, USA) and propidium iodide (PI) (Sigma), both at 1 mg/ml in PBS, for 10 min at room temperature, washed twice in PBS and mounted with 50% glycerol in PBS. Samples were analysed using an Olympus BX60¯uorescence microscope (excitation wavelength: 365 nm).
Immunofluorescence
Cytochrome c Cells were ®xed in 4% paraformaldehyde and 0.19% picric acid in PBS for 60 min, washed in PBS for 10 min and permeabilized with 0.1% SDS in PBS containing 1% FCS for 5 min before incubation with 2 mg/ml of mouse anti-cytochrome c antibody (clone 6H2-B4) for 1 h. After three washes with 1% FCS in PBS cells were incubated with 1 : 125 FITC-conjugated anti-mouse antibody (Fab'2, Sigma) for 30 min. After washing three times with 1% FCS in PBS samples were mounted with 50% glycerol in PBS.
Active caspase-3 Double staining for active caspase-3 (FITC) and nuclei (DAPI, 4',6-diamidine-2-phenylindole dihydrochloride) was performed on cytospins for U1285 cells and on cells grown on coverslips for the adherent U1810, H157 and H23 cells. Cells were ®xed in 50 and 100% acetone for 5 min each, and washed in PBS for 10 min. Biotinconjugated polyclonal anti-active caspase-3 antibody was used at 1 : 50 dilution in 0.1% Triton X-100 in PBS. After three washes in PBS, cells were incubated with 1 : 100 streptavidin-FITC for 30 min, and washed in PBS. Nuclei were co-stained with 1 mg/ml DAPI (Roche, Germany) for 10 min, washed twice in PBS and samples were mounted with antifade Polyvinyl alcohol mounting medium (Fluka, Milwaukee, WI, USA).
Cell cycle distribution analysis by flow cytometry
The distribution of cells in the G1, S and G2/M cell cycle phases was determined by DNA¯ow-cytometry as described earlier (Castro et al., 1993) . Cells were harvested at 1610 6 cells/ml, washed in PBS, ®xed in 3.8% paraformaldehyde for 30 min, resuspended in 70% ethanol and stained with propidium iodide (PI, 50 mg/ml) in presence of RNase A (0.5 mg/ml). Flow cytometric analysis was carried out using a FACScan¯ow cytometer equipped with CellQuest software (Becton Dickinson, San JoseÂ , CA, USA).
